Sports Nutrition Dosage Forms: Protein, Pre-Workout, EAA and Creatine Manufacturing Playbook

Whey protein concentrate, whey protein isolate, whey protein hydrolysate, micellar casein, milk protein concentrate, egg white protein, soy protein isolate, pea protein isolate, rice protein concentrate and emerging proteins (fava, mung, hemp, pumpkin) define the protein supplement matrix. Specifications cover protein content per nitrogen × 6.25 with disclosure of non-protein nitrogen contribution (free amino acids, creatine, taurine spiked to inflate apparent protein content — the 'protein spiking' or 'amino spiking' adulteration pattern requiring orthogonal verification by amino acid analysis or DUMAS-with-deconvolution), Protein Digestibility-Corrected Amino Acid Score (PDCAAS) or Digestible Indispensable Amino Acid Score (DIAAS) for protein quality claims, lactose content for low-lactose claims, fat and ash content, and microbiological. Manufacturing controls dispersibility (instantizing via lecithin or sunflower lecithin coating with controlled particle size for cold-water mixing), flavour and sweetener integration (high-intensity sweetener load with palatability validation across rebaudioside, sucralose, acesulfame-K, monk fruit, stevia), and packaging headspace and oxygen scavenger management for flavour stability. Plant protein matrices add the off-flavour management challenge (pea protein bitter notes, soy beany notes, rice protein chalk) requiring flavour masking systems and sometimes proteolytic modification.

Pre-workout formulations combine caffeine (typically 150-400 mg/serving), beta-alanine (1.5-3.2 g/serving for the carnosine-loading dose with characteristic paraesthesia), citrulline malate (4-8 g/serving), creatine monohydrate (3-5 g/serving), taurine, tyrosine, theanine, and a variable nootropic/stimulant adjuvant stack. The banned-substance frontier — DMAA (1,3-dimethylamylamine), DMHA, ephedrine, synephrine analogues, higenamine, methylsynephrine, halostachine, octopamine, oxilofrine, hordenine, BMPEA, deterenol — has been the dominant source of FDA warning letter and class-action exposure in pre-workout, with repeated discovery of banned stimulants in marketed products. The discipline requires per-lot mass spectrometry adulterant screen targeting the current banned-stimulant panel (FDA, WADA, NSF, BSCG, USADA lists), supplier certificate of analysis verification with orthogonal in-house re-test for any new supplier or new lot of botanical extract, formulation review against the rolling banned-substance precedent, and ingredient traceability sufficient to support root-cause investigation if a banned stimulant is detected post-market. Caffeine source identification (pure anhydrous caffeine vs guarana vs coffee bean extract vs yerba mate vs green tea extract) is required for total caffeine declaration and per-source quantification.

Essential amino acid (EAA) and branched-chain amino acid (BCAA — leucine, isoleucine, valine typically 2:1:1) blends are highly hygroscopic powders requiring strict humidity control in process and packaging. Manufacturing humidity below 40% RH at granulation and blending, desiccant and oxygen scavenger inclusion in primary packaging, and barrier packaging (foil-laminate stick packs, HDPE bottle with induction seal) are baseline requirements. Free amino acid solubility and palatability are formulation challenges — leucine in particular has limited cold-water solubility and bitter taste profile requiring micronisation, instantizing and flavour masking. Vegan EAA from fermentation (corn or sugarcane substrate) has displaced animal-sourced amino acids for the dominant share of the market, requiring fermentation source documentation and allergen status verification (corn-derived requiring corn allergen disclosure where applicable, fermentation-derived flagged as fermented food product where required). Identity is by HPLC amino acid analysis with full ratio verification — BCAA SKUs frequently fail identity on supplier mis-blend with the spec ratio drifted from 2:1:1.

Creatine monohydrate is the most studied sports nutrition ingredient and the dominant form despite a continuing market for creatine hydrochloride, ethyl ester, malate and buffered variants (none with the evidence depth of monohydrate). Specifications cover purity (Creapure trademark from AlzChem dominates the premium segment with ≥99.95% creatine monohydrate and explicit creatinine, dicyandiamide and dihydrotriazine impurity ceilings, with non-Creapure sources requiring equivalent in-house verification), particle size (200-mesh micronised creatine for dispersibility in cold water vs standard mesh for capsules and tablets), dissolution and stability in solution (creatine monohydrate degrades to creatinine in solution with the rate accelerated by acidity and temperature, driving the dry-powder dosage form dominance and the avoidance of pre-dissolved creatine RTD products). Heavy metals and microbiological per USP general chapters. Adulteration risk with cheaper creatinine or undeclared excipient is a documented historical issue requiring orthogonal identity verification (HPLC purity and creatinine, IR identity).

Sports-certification readiness covers NSF Certified for Sport, Informed Sport, Informed Choice, BSCG Certified Drug Free, Cologne List and Banned Substances Control Group programmes — see the sports certification guide. Each programme adds lot-by-lot finished-product testing against the relevant banned substance list (WADA Prohibited List as the common anchor, with programme-specific extensions), facility audit and ingredient supplier qualification at the certification scope. Label discipline includes the structure/function vs performance enhancement claim boundary (US DSHEA permits 'supports muscle protein synthesis' but not 'builds muscle mass'; FTC competent and reliable scientific evidence required; FDA-defined athletic performance claim exclusion vs structure/function permissibility), full caffeine quantification per serving with source identification, beta-alanine warning text where loading-dose paraesthesia is foreseeable, and protein source allergen disclosure (milk, soy, egg, tree nut, sesame). Athlete pharmacovigilance includes a dedicated intake channel for sports-tested athlete adverse-finding reports (a positive WADA test traced to a contaminated supplement is a major commercial event with potential athlete sanction and litigation exposure), supplier-audit-back capability to identify the contamination root cause, and full retention sample programme supporting analytical investigation up to and beyond the lot expiry date.